{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:17:58Z","timestamp":1793755078509,"version":"4.6.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T00:00:00Z","timestamp":1480377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00393-016-0236-6","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T01:59:55Z","timestamp":1480384795000},"page":"249-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Role of methotrexate chronotherapy in collagen-induced rheumatoid arthritis in\u00a0rats","Bedeutung der Methotrexat-Chronotherapie bei kollageninduzierter rheumatoider Arthritis von Ratten"],"prefix":"10.1007","volume":"77","author":[{"given":"X.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,29]]},"reference":[{"key":"236_CR1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376:1094\u20131108","journal-title":"Lancet"},{"key":"236_CR2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","volume":"359","author":"HK Choi","year":"2002","unstructured":"Choi HK, Hern\u00e1n MA, Seeger JD, Robins JM, Wolfe F (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a\u00a0prospective study. Lancet 359:1173\u20131177","journal-title":"Lancet"},{"key":"236_CR3","first-page":"168","volume":"65","author":"H Tian","year":"2007","unstructured":"Tian H, Cronstein BN (2007) Understanding the Mechanism of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Jt Dis 65:168\u2013173","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"236_CR4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/ard.2005.048637","volume":"65","author":"NP Riksen","year":"2006","unstructured":"Riksen NP, Barrera P, van den Broek PH (2006) Methotrexate modulates the kinetics of adenosine in humans in vivo. Ann Rheum Dis 65:465\u2013470","journal-title":"Ann Rheum Dis"},{"key":"236_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00296-002-0186-y","volume":"22","author":"S Pandya","year":"2002","unstructured":"Pandya S, Aggarwal A, Misra R (2002) Methotrexate twice weekly vs once weekly in rheumatoid arthritis: a\u00a0pilot double-blind, controlled study. Rheumatol Int 22:1\u20134","journal-title":"Rheumatol Int"},{"key":"236_CR6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","volume":"14","author":"M Feldman","year":"1996","unstructured":"Feldman M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397\u2013440","journal-title":"Annu Rev Immunol"},{"key":"236_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ncprheum0020","volume":"1","author":"IB Mcinnes","year":"2005","unstructured":"Mcinnes IB, Liew FY (2005) Cytokine networks-towards new therapies for rheumatoid arthritis. Nat Clin Pract Rheumatol 1:31\u201339","journal-title":"Nat Clin Pract Rheumatol"},{"key":"236_CR8","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1210\/jcem.82.4.3852","volume":"82","author":"LJ Crofford","year":"1997","unstructured":"Crofford LJ, Kalogeras KT, Mastorakos G (1997) Circadian relationships between interleukin (IL)-6 and hypothalamicpituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 82:1279\u20131283","journal-title":"J Clin Endocrinol Metab"},{"key":"236_CR9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/ard.62.7.593","volume":"62","author":"M Cutolo","year":"2003","unstructured":"Cutolo M, Seriolo B, Craviotto C (2003) Circadian rhythms in RA. Ann Rheum Dis 62:593\u2013596","journal-title":"Ann Rheum Dis"},{"key":"236_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/ard.2007.086561","volume":"68","author":"MG Perry","year":"2009","unstructured":"Perry MG, Kirwan JR, Jessop DS, Hunt LP (2009) Overnight variations in cortisol, interleukin 6, tumor necrosis factor-\u03b1 and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis 68:63\u201368","journal-title":"Ann Rheum Dis"},{"key":"236_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/ard.56.1.27","volume":"56","author":"NG Arvidson","year":"1997","unstructured":"Arvidson NG, Gudbj\u00f6rnsson B, Larsson A, H\u00e4llgren R (1997) The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis 56:27\u201331","journal-title":"Ann Rheum Dis"},{"key":"236_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(08)60132-4","volume":"371","author":"F Buttgereit","year":"2008","unstructured":"Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E (2008) Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a\u00a0double-blind, randomized controlled trial. Lancet 371:205\u2013214","journal-title":"Lancet"},{"key":"236_CR13","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1211\/jpp.61.10.0009","volume":"61","author":"H To","year":"2009","unstructured":"To H, Irie S, Tomonari M, Watanabe Y, Kitahara T, Sasaki H (2009) Therapeutic index of methotrexate depends on circadian cycling of tumour necrosis factor-alpha in collagen-induced arthritic rats and mice. J Pharm Pharmacol 61:1333\u20131338","journal-title":"J Pharm Pharmacol"},{"key":"236_CR14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/07420528.2011.553017","volume":"28","author":"H To","year":"2011","unstructured":"To H, Yoshimatsu H, Tomonari M, Ida H, Tsurumoto T, Tsuji Y (2011) Methotrexate chronotherapy is effective against rheumatoid arthritis. Chronobiol Int 28:267\u2013274","journal-title":"Chronobiol Int"},{"key":"236_CR15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1254\/jphs.11029FP","volume":"116","author":"K Obayashi","year":"2011","unstructured":"Obayashi K, Tomonari M, Yoshimatsu H, Fukuyama R, Ieiri I, Higuchi S (2011) Dosing time-dependency of the arthritis-inhibiting effect of tacrolimus in mice. J Pharmacol Sci 116:264\u2013273","journal-title":"J Pharmacol Sci"},{"key":"236_CR16","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1016\/S0041-1345(99)00559-X","volume":"31","author":"S Hishikawa","year":"1999","unstructured":"Hishikawa S, To H, Kobayashi E, Uchida H, Fujimura A (1999) Chronotoxicity of mizoribine under repeated administration in the rat. Transplant Proc 31:2765\u20132766","journal-title":"Transplant Proc"},{"key":"236_CR17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1254\/jphs.12059FP","volume":"120","author":"Y Kanasaki","year":"2012","unstructured":"Kanasaki Y, Tomonari M, Sasaki H, To H (2012) Chronopharmacology of mizorribine in collagen-induced arthritis rats. J Pharmacol Sci 120:112\u2013120","journal-title":"J Pharmacol Sci"},{"key":"236_CR18","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/jn\/134.8.1964","volume":"134","author":"E Baharav","year":"2004","unstructured":"Baharav E, Mor F, Halpern M, Weinberger A (2004) Lactobacillus GG bactofia ameliorate arthritis in Lewis rats. J\u00a0Nutr 134:1964\u20131969","journal-title":"J Nutr"},{"key":"236_CR19","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1023\/A:1011903100188","volume":"15","author":"A Bendele","year":"1998","unstructured":"Bendele A (1998) Effects of interleukin-1 receptor antagonist in a\u00a0slow-release hylan vehicle on rat type II collagen. Pharm Res 15:1557\u20131561","journal-title":"Pharm Res"},{"key":"236_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.30070","volume":"63","author":"F Buttgereit","year":"2011","unstructured":"Buttgereit F, Burmester GR, Starub RH (2011) Exogenous and endogenous glucocorticoids in rheumatic diseases. Arthritis Rheum 63:1\u20139","journal-title":"Arthritis Rheum"},{"key":"236_CR21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.22368","volume":"56","author":"RH Straub","year":"2007","unstructured":"Straub RH, Cutolo M (2007) Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum 56:399\u2013408","journal-title":"Arthritis Rheum"},{"key":"236_CR22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1084\/jem.146.3.857","volume":"146","author":"DE Trentham","year":"1997","unstructured":"Trentham DE, Tuwnes AS, Kang AH (1997) Autoimmunity to type II collagen an experimental model of arthritis. J\u00a0Exp Med 146:857\u2013868","journal-title":"J Exp Med"},{"key":"236_CR23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/art.38871","volume":"67","author":"C Sohc","year":"2015","unstructured":"Sohc C, Lee A, Qiao Y et al (2015) Prolonged TNF primes firoblast-like synoviocytes in a\u00a0gene-specifi manner by altering chromatin. Arthritis Rheum 67:86\u201395","journal-title":"Arthritis Rheum"},{"key":"236_CR24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1172\/JCI1379","volume":"101","author":"AJ Puren","year":"1998","unstructured":"Puren AJ, Fantuzzi G, Gu Y et al (1998) Interleukin-18 induces IL-8 and IL-1via TNF production from non-CD14+ human blood mononuclear cells. J\u00a0Clin Invest 101:711\u2013721","journal-title":"J Clin Invest"},{"key":"236_CR25","first-page":"271","volume":"227B","author":"M Herold","year":"1987","unstructured":"Herold M, Gunther R (1987) Circadian rhythm of C\u2011reactive protein in patients with rheumatoid arthritis. Prog Clin Biol Res 227B:271\u2013279","journal-title":"Prog Clin Biol Res"},{"key":"236_CR26","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1002\/art.21532","volume":"52","author":"I G\u00e1l","year":"2005","unstructured":"G\u00e1l I, Bajnok E, Sz\u00e1nt\u00f3 S, Sarraj B, Glant TT, Mikecz K (2005) Visualization and in situ analysis of leukocyte trafficking into the ankle joint in a\u00a0systemic murine model of rheumatoid arthritis. Arthritis Rheum 52:3269\u20133278","journal-title":"Arthritis Rheum"},{"key":"236_CR27","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1111\/j.1742-4658.2006.05441.x","volume":"273","author":"NC Kaneider","year":"2006","unstructured":"Kaneider NC, Leger AJ, Kuliopulos A (2006) Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions. FEBS J 273:4416\u20134424","journal-title":"FEBS J."},{"key":"236_CR28","first-page":"810","volume":"25","author":"Y Ueki","year":"2007","unstructured":"Ueki Y, Sagawa A, Tanimura K, Yamada A, Yamamoto K, Tsuda HA (2007) Multicenter study of leukocytapheresis in rheumatoid arthritis. Clin Exp Rheumatol 25:810\u2013816","journal-title":"Clin Exp Rheumatol"},{"key":"236_CR29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF00265390","volume":"9","author":"J English","year":"1982","unstructured":"English J, Aherne W, Marks V (1982) The effect of timing of a\u00a0single injection on the toxicity of methotrexate in the rat. Cancer Chemother Pharmacol 9:114\u2013117","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-016-0236-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0236-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-016-0236-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T03:24:42Z","timestamp":1522812282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-016-0236-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,29]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["236"],"URL":"https:\/\/doi.org\/10.1007\/s00393-016-0236-6","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,29]]}}}